SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sensus Healthcare, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.76−0.01 (-0.36%)
Close on Oct 19, 2026
- Market cap
- $45.44M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.44 (−13.75%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Sensus Healthcare, Inc. saw revenue fall 53.4% to $17.51M over the twelve months to Jun 30, 2026. Free cash flow was -$6.97M, down 299.6% from a year earlier.
Revenue
$17.51M
-53.4% vs. a year earlier
Operating income
-$13.26M
TTM Q2 2026
Free cash flow
-$6.97M
-299.6% vs. a year earlier
EPS, diluted
-$0.94
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $45.44M
- P/E ratio
- –
- Price to sales
- 2.60
- Price to book
- 1.23
- Dividend yield
- –
- Free cash flow yield
- -15.34%
Fundamentals
- Revenue
- $17.51M
- Net income
- -$15.49M
- EPS, diluted
- -$0.94
- Free cash flow
- -$6.97M
- Book value per share
- $2.24
- Diluted shares
- 16M
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
$17.51M-53.4% YoY
Gross profit
$6.37M-67.5% YoY
Operating income
-$13.26M
Net income
-$15.49M
EPS, diluted
-$0.94
Free cash flow
-$6.97M-299.6% YoY
Reported periodTrailing twelve months